Are Women of Childbearing Age Still Receiving Valproate?
作者信息
Birnbaum Angela K
出版信息
Epilepsy Curr. 2018 Nov-Dec;18(6):380-381. doi: 10.5698/1535-7597.18.6.380.
Abstract
摘要
相似文献
1
Are Women of Childbearing Age Still Receiving Valproate?育龄期女性仍在使用丙戊酸盐吗？
Epilepsy Curr. 2018 Nov-Dec;18(6):380-381. doi: 10.5698/1535-7597.18.6.380.
2
A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.一项针对育龄期女性双相情感障碍患者丙戊酸钠处方质量的英国临床审计。
BMJ Open. 2018 Apr 12;8(4):e020450. doi: 10.1136/bmjopen-2017-020450.
3
Valproate in the treatment of epilepsy in girls and women of childbearing potential.丙戊酸盐用于治疗有生育潜力的女童和女性的癫痫。
Epilepsia. 2015 Jul;56(7):1006-19. doi: 10.1111/epi.13021. Epub 2015 May 16.
4
Treatment decisions in women of childbearing age on valproate.生育年龄女性使用丙戊酸盐的治疗决策。
Acta Neurol Scand. 2020 Apr;141(4):287-293. doi: 10.1111/ane.13211. Epub 2020 Jan 21.
5
[Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data].[德国育龄期女孩和妇女丙戊酸盐的处方开具：基于索赔数据的趋势分析]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Aug;61(8):1022-1029. doi: 10.1007/s00103-018-2768-1.
6
Why Do Psychiatrists Still Prescribe Valproate to Women of Childbearing Potential?为什么精神科医生仍在为有生育潜力的女性开丙戊酸盐？
Front Psychiatry. 2020 Jul 24;11:739. doi: 10.3389/fpsyt.2020.00739. eCollection 2020.
7
Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.服用丙戊酸盐治疗癫痫的女性中的多囊卵巢和高雄激素血症
N Engl J Med. 1993 Nov 4;329(19):1383-8. doi: 10.1056/NEJM199311043291904.
8
Pharmacokinetic variability of valproate in women of childbearing age.育龄期女性丙戊酸盐的药代动力学变异性
Epilepsia. 2017 Oct;58(10):e142-e146. doi: 10.1111/epi.13872. Epub 2017 Aug 22.
9
Prescription patterns of antiepileptic drugs in Kazakhstan in 2018: A retrospective study of 57,959 patients.2018 年哈萨克斯坦抗癫痫药物处方模式：57959 例患者的回顾性研究。
Epilepsy Behav. 2019 Oct;99:106445. doi: 10.1016/j.yebeh.2019.106445. Epub 2019 Sep 11.
10
Expert advice on the management of valproate in women with bipolar disorder at childbearing age.育龄期双相障碍女性患者中丙戊酸盐管理的专家建议。
Eur Neuropsychopharmacol. 2019 Nov;29(11):1199-1212. doi: 10.1016/j.euroneuro.2019.09.007. Epub 2019 Oct 4.
本文引用的文献
1
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.八款不同抗癫痫药物致主要先天畸形的比较风险：EURAP 注册前瞻性队列研究。
Lancet Neurol. 2018 Jun;17(6):530-538. doi: 10.1016/S1474-4422(18)30107-8. Epub 2018 Apr 18.
2
Declining trend in valproate use in Finland among females of childbearing age in 2012-2016 - a nationwide registry-based outpatient study.2012-2016 年间芬兰育龄女性中丙戊酸使用呈下降趋势——一项基于全国登记的门诊研究。
Eur J Neurol. 2018 Jun;25(6):869-874. doi: 10.1111/ene.13610. Epub 2018 Mar 31.
3
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.胎儿抗癫痫药物暴露与 6 岁时的认知结局（NEAD 研究）：一项前瞻性观察研究。
Lancet Neurol. 2013 Mar;12(3):244-52. doi: 10.1016/S1474-4422(12)70323-X. Epub 2013 Jan 23.
4
Comparative safety of antiepileptic drugs during pregnancy.抗癫痫药物在妊娠期的安全性比较。
Neurology. 2012 May 22;78(21):1692-9. doi: 10.1212/WNL.0b013e3182574f39. Epub 2012 May 2.
5
Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society.癫痫女性的管理问题——聚焦妊娠（循证综述）：II. 致畸作用与围产期结局：美国神经病学学会和美国癫痫协会质量标准小组委员会及治疗与技术小组委员会报告
Epilepsia. 2009 May;50(5):1237-46. doi: 10.1111/j.1528-1167.2009.02129.x.
6
Possible teratogenicity of valproic acid.丙戊酸可能具有致畸性。
J Pediatr. 1981 Mar;98(3):508-9. doi: 10.1016/s0022-3476(81)80743-3.
7
Teratogenicity of valproic acid.
J Pediatr. 1980 Aug;97(2):332-3. doi: 10.1016/s0022-3476(80)80517-8.
8
Transmission of valproic acid (Depakene) across the placenta: half-life of the drug in mother and baby.丙戊酸（德巴金）经胎盘的转运：药物在母婴体内的半衰期
J Pediatr. 1979 May;94(5):832-5. doi: 10.1016/s0022-3476(79)80172-9.
Zotero 插件